Načítá se...
CAR T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
Immunotherapy with T cells genetically modified to express chimeric antigen receptors (CARs) that target tumor-associated molecules have impressive efficacy in hematological malignancies. The field has now embraced the challenge of applying this approach to treat common epithelial malignancies, whic...
Uloženo v:
| Vydáno v: | J Immunol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5957501/ https://ncbi.nlm.nih.gov/pubmed/29311388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701155 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|